IDiyas

For the Inventor, By the Inventor

Cambridge, MA, United States of America

Momenta Pharmaceuticals, Inc.


USPTO Granted Patents = 116



Trademarks = 6

Forward Citations = 732

Loading Chart...
Loading Chart...

139 inventors (with patents filed for the assignee):

goldMedal Carlos J Bosques (34 out of 44 patents)

silverMedal Zachary Shriver (24 out of 85 patents)

bronzeMedal Jonathan C Lansing (16 out of 19 patents)

4.  Nur Sibel Gunay (15 out of 17 patents)

5.  Leona E Ling (13 out of 14 patents)

6.  James Meador, Iii (13 out of 14 patents)

7.  Holly Prentice (12 out of 15 patents)

8.  Brian Edward Collins (12 out of 12 patents)

9.  Ian Christopher Parsons (12 out of 12 patents)

10.  Nathaniel J Washburn (11 out of 12 patents)

11.  Sucharita Roy (11 out of 11 patents)

12.  Xiangping Zhu (11 out of 11 patents)

13.  Corinne Bauer (11 out of 11 patents)

14.  Ishan Capila (11 out of 17 patents)

15.  Yanjie Jiang (10 out of 10 patents)


Core Competencies:
Integrin Alpha 11 Beta 1
Engineered Fc Constructs
Neurodegeneration Treatment
FcRn Antibodies
Sialylated Glycoproteins
Therapeutic Protein Manufacturing
CTLA4-Fc Fusion Proteins
N-Glycan Separation
Cell Culture Process
Modified Glycoproteins
Amino Acid Copolymer Analysis
Hair Growth Promotion

116 patents:

1. 12460006 - Antibodies against integrin alpha 11 beta 1 (2025-11-04),
2. 12391759 - Methods related to engineered Fc constructs (2025-08-19),
3. 12360119 - Methods related to biologics (2025-07-15),
4. 12304950 - Methods of producing ustekinumab (2025-05-20),
5. 12297291 - Compositions and methods related to engineered Fc constructs (2025-05-13),
6. 12297256 - Methods for the treatment of neurodegeneration (2025-05-13),
7. 12163951 - Methods for predicting response to treatment (2024-12-10),
8. 12139735 - Cell culture process (2024-11-12),
9. 12071482 - Compositions and methods related to engineered Fc constructs (2024-08-27),
10. 11827682 - Engineered Fc constructs (2023-11-28),
11. 11773168 - FcRn antibodies and methods of use thereof (2023-10-03),
12. 11732047 - FcRn antibodies and methods of use thereof (2023-08-22),
13. 11719704 - Methods related to biologics (2023-08-08),
14. 11661456 - Sialylated glycoproteins (2023-05-30),
15. 11639923 - Methods for predicting response to treatment (2023-05-02),
Momenta Pharmaceuticals, Inc. is a biotechnology company that focuses on developing innovative therapies for autoimmune and rare diseases. They employ cutting-edge technologies and proprietary science to discover, develop, and commercialize biosimilar and novel therapeutics. Momenta Pharmaceuticals is committed to improving patient's lives through quality treatments and creating value for their shareholders.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

...
116 Patents

#23 in Cambridge, MA

#178 in Massachusetts

#3,188 in US

#6,637 in the World

...
Cambridge, MA, United States of America

Momenta Pharmaceuticals, Inc.

Forward Citations = 732

139 inventors:

goldMedal Carlos J Bosques (34 out of 44 patents)

silverMedal Zachary Shriver (24 out of 85 patents)

bronzeMedal Jonathan C Lansing (16 out of 19 patents)

4.  Nur Sibel Gunay (15 out of 17 patents)

5.  Leona E Ling (13 out of 14 patents)

Please report any incorrect information to support@idiyas.com
Loading…